icon
沙特阿拉伯王国政府所属的官方政府网站。
icon 周六 15 八月 2026
icon
沙特官方政府网站的域名以下列后缀结尾 gov.sa

沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

在数字政府管理局注册,编号:

20250831619
建议

Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)

Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)

icon 2020-07-04
عنوان الدراسة
Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI)
داعم الدراسة
KAIMRC
دواء الدراسة
NILOTINIB
رقم بروتوكول الدراسة
RC12/052/R
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
مرحلة الدراسة
4